Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (2)
  • 2023 (2)
  • 2022 (2)

Subject

  • Drug Trafficking (125)
  • Synthetic drugs (113)
  • Arrests/Convictions - Major (85)
  • Overdose (43)
  • Guns/Weapons (29)
  • Guilty Plea (28)
  • Seizures (Drugs/Property) (28)
  • Fake Pills (22)
  • Prescription Drugs (18)
  • Major Law Enforcement Operation (17)
  • OCDETF/Task Force (17)
  • Money Laundering (13)
  • Take Back Day (13)
  • Extraditions (12)
  • Pharmaceuticals/Pharmacists/Physicians (12)
  • Gangs (9)
  • Outreach/Drug Prevention (6)
  • Task Forces/Task Force Officers (6)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Dark Web- Internet Trafficking (2)
  • Fentanyl Awareness (2)
  • Asset Forfeiture (1)
  • Congressional Affairs (1)
  • HIDTA (1)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Red Ribbon (1)
  • Terrorism (1)
  • Diversion Division (10)

Drug Name

  • Opioids (1)

Field Division

  • Washington, DC (34)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (18)
  • Houston (15)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (9)
  • New Orleans (8)
  • Sede (8)
  • St. Louis (7)
  • El Paso (6)
  • Dallas (5)
  • Rocky Mountain (5)
  • Los Angeles (3)
  • Omaha (3)
  • Phoenix (3)
  • Louisville (2)
  • Detroit (1)
  • San Francisco (7)
  • San Diego (3)
Clear All Results
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 20, 2025
SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
Noviembre 20, 2025
PRESS RELEASE

Communities Nationwide Join DEA and its Partners to Safely Dispose of 571,000 pounds of Unwanted Medications

Noviembre 03, 2025
SAN FRANCISCO – On October 25, 2025, DEA joined 4,263 law enforcement agencies across the country who came together for the 29th National Prescription Drug Take Back Day. At 4,317 collection sites nationwide, Take Back events removed 571,054 pounds of unneeded and expired medications from home medicine cabinets to prevent...
Noviembre 03, 2025
PRESS RELEASE

Sacramento Doctor Agrees to Pay $125,000 for Controlled Substances Act Violations at Sutter Imaging Capitol Pavilion

Junio 04, 2025
SACRAMENTO, Calif. — Philip Yen, M.D. has agreed to pay the United States $125,000 to resolve allegations that he failed to comply with federal statutory requirements related to his role as the Drug Enforcement Administration registrant at Sutter Imaging Capitol Pavilion, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration...
Junio 04, 2025
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

Enero 14, 2025
SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...
Enero 14, 2025
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

Junio 27, 2024
SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
Junio 27, 2024
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

Junio 03, 2024
SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
Junio 03, 2024
PRESS RELEASE

CA Attorney General Bonta Announces Arrest of Santa Clara Doctor for Illegal Opioid Prescription Scheme

Agosto 11, 2023
SANTA CLARA, Calif. — California Attorney General Rob Bonta today announced the arrest of and filing of charges against Dr. Arash Padidar, a Santa Clara County doctor accused of illegally prescribing opioids to patients. The arrest and charges are the result of an investigation into an alleged two-years-long illegal prescription...
Agosto 11, 2023
PRESS RELEASE

Former Modesto Doctor Pleads Guilty to Illegally Prescribing Opioids

Mayo 11, 2023
FRESNO, Calif. — Sawtantra Chopra, 76, of Modesto, pleaded guilty Wednesday to three counts of illegally prescribing opioids and other medication, U.S. Attorney Phillip A. Talbert and Drug Enforcement Administration Special Agent in Charge Brian M. Clark announced. According to court documents, Chopra admitted prescribing drugs — including hydrocodone, alprazolam...
Mayo 11, 2023
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

Merced County Doctor Indicted for Multimillion Dollar Disability Insurance Fraud Scheme, Money Laundering, and Unrelated Drug Charges

Octubre 27, 2022
FRESNO, Calif. — On Oct. 20, 2022, a federal grand jury charged Sohail Mamdani, 46, of Los Banos, with mail fraud and money laundering in connection to a disability insurance fraud scheme, and unlawful use of a DEA registration number and fraudulently obtaining possession of a controlled substance, U.S. Attorney...
Octubre 27, 2022
Showing 1 - 10 of 10 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster